Lupin Limited has informed the Exchange regarding a press release dated May 08, 2025, titled "Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg".
Press Release May 08 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release May 07 2025
- Press Release Apr 24 2025
- Press Release Apr 23 2025
- Press Release Apr 17 2025
- Lupin Announces the Acquisition of Renascience in the United Kingdom
Later from Lupin
- Press Release May 13 2025
- Press Release May 14 2025
- Press Release May 15 2025
- Press Release May 20 2025
- Press Release May 26 2025
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin